Shaw; Gray D

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shaw; Gray D.The latest application filed is for "variants of igg fc with limited amine groups".

Company Profile

4.12.16

Shaw; Gray D - Half Moon Bay CA US
Shaw; Gray D. - Milton MA
Shaw; Gray D - Redwood City CA US
Shaw; Gray D. - Redwood City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Variants of IgG Fc with limited amine groups Grant 10,421,796 - Shaw Sept	2019-09-24
Variants of IgG-Fc fusion that provide for site-specific conjugation at the N-terminus Grant 10,214,578 - Shaw Feb	2019-02-26
Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets Grant 9,266,923 - Shaw February 23, 2	2016-02-23
Variants of IgG Fc with Limited Amine Groups App 20150203576 - Shaw; Gray D	2015-07-23
Soluble tandem selectin glycoprotein ligand molecules Grant 8,889,628 - Shaw November 18, 2	2014-11-18
Novel Enhanced Selectin Antagonists App 20130136741 - Shaw; Gray D.	2013-05-30
Compositions and Methods for Treatment of Thrombosis and for Prolonging Survival of Stored Platelets App 20120165258 - Shaw; Gray D.	2012-06-28
Platelet Glycoprotein Ib Alpha Fusion Polypeptides And Methods Of Use Thereof App 20090148427 - Shaw; Gray D. ; et al.	2009-06-11
Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligand (PSGL-1) binding protein Grant 7,405,272 - Lorenz , et al. July 29, 2	2008-07-29
Sulfotyrosine Specific Antibodies And Uses Therefor App 20070298034 - Widom; Angela ; et al.	2007-12-27
Method of treating disorders using platelet glycoprotein Ib alpha fusion polypeptides App 20070274999 - Shaw; Gray D.	2007-11-29
Neutralizing Antibodies Against Primate Psgl-1 And Uses Therefor App 20070160601 - Widom; Angela ; et al.	2007-07-12
Sulfotyrosine Specific Antibodies And Uses Therefor App 20070154472 - Widom; Angela ; et al.	2007-07-05
Platlet glycoprotein Ib alpha fusion polypeptides and methods of use thereof App 20060140935 - Shaw; Gray D. ; et al.	2006-06-29
Platelet glycoprotein Ib.alpha. fusion polypeptides and methods of use thereof Grant 7,049,128 - Shaw , et al. May 23, 2	2006-05-23
Platelet glycoprotein Ib alpha fusion polypeptides and methods of use thereof App 20060093614 - Shaw; Gray D. ; et al.	2006-05-04
Platlet glycoprotein IB.alpha. fusion polypeptides and methods of use thereof Grant 6,991,796 - Shaw , et al. January 31, 2	2006-01-31
Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor App 20050152904 - Lorenz, Meike ; et al.	2005-07-14
Methods of identifying compounds which inhibit binding of SLIC-1 to PSGL-1 Grant 6,852,497 - Lorenz , et al. February 8, 2	2005-02-08
Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof App 20030232047 - Shaw, Gray D. ; et al.	2003-12-18
Platlet glycoprotein Ib alpha fusion polypeptides and methods of use thereof App 20030091576 - Shaw, Gray D. ; et al.	2003-05-15
Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor App 20020037840 - Lorenz, Meike ; et al.	2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.